Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. 

CEO
Christophe Weber
CEOChristophe Weber
Employees
49,095
Employees49,095
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
49,095
Employees49,095

TAK Key Statistics

Market cap
42.11B
Market cap42.11B
Price-Earnings ratio
32.19
Price-Earnings ratio32.19
Dividend yield
4.29%
Dividend yield4.29%
Average volume
1.36M
Average volume1.36M
High today
$13.28
High today$13.28
Low today
$13.09
Low today$13.09
Open price
$13.09
Open price$13.09
Volume
1.24M
Volume1.24M
52 Week high
$17.12
52 Week high$17.12
52 Week low
$13.01
52 Week low$13.01

TAK News

Yahoo Finance 2d
Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. Looks Ripe for a Turnaround - Yahoo Finance

Takeda Pharmaceutical Co. (TAK) has been beaten down lately with too much selling pressure. While the stock has lost 6.2% over the past four weeks, there is lig...

Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. Looks Ripe for a Turnaround - Yahoo Finance
Seeking Alpha 5d
Bristol, Sanofi, Takeda gain positive CHMP recommendations

The European Medicines Agency's Committee for Medicinal Products for Human Use has issued positive opinions for treatments from Bristol-Myers Squibb (NYSE:BMY),...

Bristol, Sanofi, Takeda gain positive CHMP recommendations
Seeking Alpha 6d
Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data - Seeking Alpha

andresr/E+ via Getty Images Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was able to report positive results from its phase 2 SAVITRI study, which used a drug kn...

Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data - Seeking Alpha

Analyst ratings

60%

of 15 ratings
Buy
40%
Hold
60%
Sell
0%

More TAK News

Seeking Alpha 6d
Takeda said to have left industry trade group BIO

Takeda Pharmaceutical (NYSE:TAK) has decided to part ways with the biotech industry's top lobbying group, the Biotechnology Innovation Organization (BIO), Stat...

Takeda said to have left industry trade group BIO
Yahoo Finance 6d
All You Need to Know About Takeda Pharmaceutical Co. Rating Upgrade to Strong Buy - Yahoo Finance

Takeda Pharmaceutical Co. (TAK) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily ref...

All You Need to Know About Takeda Pharmaceutical Co. Rating Upgrade to Strong Buy - Yahoo Finance
Yahoo Finance 6d
Should Value Investors Buy Takeda Pharmaceutical Co. Stock? - Yahoo Finance

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also...

Should Value Investors Buy Takeda Pharmaceutical Co. Stock? - Yahoo Finance
Yahoo Finance 7d
Best Income Stocks to Buy for April 25th - Yahoo Finance

Here are three stocks with buy rank and strong income characteristics for investors to consider today, April 25th: Bancolombia S.A. CIB: This company that prov...

Best Income Stocks to Buy for April 25th - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.